Antonino Dimarco
Internal Medicine · Rome, NYNPI 1922002393
Payments from drug & device makers
Across 237 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$553
- Novartis$549
- Novo Nordisk$449
- Lilly USA, LLC$345
- AstraZeneca$341
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$336
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,18499%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 17 | $553 |
| Novartis | 30 | $549 |
| Novo Nordisk | 30 | $449 |
| Lilly USA, LLC | 22 | $345 |
| AstraZeneca | 23 | $341 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $336 |
| GSK | 19 | $314 |
| Boehringer Ingelheim | 10 | $181 |
| Abbott | 7 | $136 |
| Actelion Pharmaceuticals US, Inc. | 5 | $117 |
| Johnson & Johnson | 6 | $108 |
| Merck | 7 | $108 |
| Kowa Pharmaceuticals America, Inc. | 6 | $105 |
| Sanofi-aventis U.S. LLC | 5 | $92 |
| Mylan Specialty L.p. | 6 | $90 |
| Amarin Pharma, Inc. | 5 | $73 |
| Avanir Pharmaceuticals, Inc. | 4 | $55 |
| Dexcom, Inc. | 2 | $47 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Grifols USA, LLC | 2 | $38 |
| Pfizer | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| United Therapeutics Corporation | 1 | $22 |
| Medicomp Inc | 1 | $12 |
| Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,213 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 16 | $234 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rome
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.